Hu Ge

机构：Qingdao University, Zhengzhou University, First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Henan Cancer Hospital, Jiangxi Academy of Agricultural Sciences, First Affiliated Hospital Zhejiang University · ORCID：0000-0002-5424-5172

发表论文 17 篇 · 总被引 195 次 · h-index 8

代表论文

• FOXK transcription factors: Regulation and critical role in cancer (2019 · Cancer Letters · 被引 70)
• PBX1 is a valuable prognostic biomarker for patients with breast cancer (2020 · Experimental and Therapeutic Medicine · 被引 32)
• SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis (2024 · Nature Communications · 被引 23)
• Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles (2018 · Life Sciences · 被引 19)
• Syntheses and characterization of non-bisphosphonate quinoline derivatives as new FPPS inhibitors (2013 · Biochimica et Biophysica Acta (BBA) - General Subjects · 被引 16)
• Comprehensive folding variations for protein folding (2022 · Proteins Structure Function and Bioinformatics · 被引 12)